Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Cash flows from operating activities
Net loss	$ (7,530,361)	$ (14,080,454)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation	14,230	1,767
Amortization	424,812	424,813
Impairment expense	1,270,115	0
Stock-based compensation - employees	682,000	7,777,900
Stock-based compensation - non-employees	89,741	1,587,200
Non-cash interest expense	2,385,807	1,972,836
Non-cash interest expense – related parties	353,326	336,139
Deferred lease expense	217,210	54,302
Change in fair value of patent acquisition liability	390,000
Foreign exchange (gain) loss	(91,963)	89,125
Changes in operating assets and liabilities which provided (used) cash
Other receivable	(196,343)	(222,562)
Accounts payable	95,049	(75,147)
Accounts payable – related parties	65,873	(51,008)
Accrued expenses	106,503	8,227
Net cash used in operating activities	(1,724,001)	(2,176,862)
Cash flows from investing activities
Advance on business acquisition	(100,000)	(350,000)
Leasehold improvements in progress	(5,439)	(160,724)
Net cash used in investing activities	(105,439)	(510,724)
Cash flows from financing activities
Issuance of loans payable	380,000
Repayment of loans payable	(230,000)
Issuance of loans payable – related parties	225,000
Repayment of loans payable – related parties		(10,000)
Issuance of convertible notes	1,565,887	2,220,193
Repayment of convertible notes	(21,600)
Issuance of convertible notes - related parties		500,000
Repayment of convertible notes - related parties	(171,632)
Preferred stock buy-back		(10)
Net cash provided by financing activities	1,747,655	2,710,183
Net (decrease) increase in cash and cash equivalents	(81,785)	22,597
Cash and cash equivalents, beginning of year	84,978	62,381
Cash and cash equivalents, end of year	3,193	84,978
Supplemental cash flows disclosures
Cash paid for interest	66,006	68,127
Non-cash transactions - investing and financing activities
Patent acquisition liability modification	4,380,000
Conversion of rents due to convertible loan		271,512
Accrued expense converted to convertible loans		552,935
Acquisition of equipment in exchange for loan payable from R&D Labs, a related party		300,000
Sale of equipment in exchange for note receivable - related party		44,859
Distribution		$ 255,141